Japan Artemisinin Derivatives Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Artemisinin Derivatives market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Artemisinin Derivatives market. Detailed analysis of key players, along with key growth strategies adopted by Artemisinin Derivatives industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Guangxi Xiancaotang Pharmaceutical

    • Sanofi

    • Shanghai Natural Bio-engineering Co

    • KPC Pharmaceuticals

    • Guilin Pharmaceutical

    • Kerui Nanhai Pharmaceutical

    • Novanat Bioresource

    • Botanical Extracts EPZ Ltd

    By Type:

    • Dihydroartemisinin

    • Artemisunate

    • Others

    By End-User:

    • Malaria Treatment

    • Scientific Research

    • Others

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Artemisinin Derivatives Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Artemisinin Derivatives Market Size and Growth Rate of Dihydroartemisinin from 2014 to 2026

      • 1.3.2 Japan Artemisinin Derivatives Market Size and Growth Rate of Artemisunate from 2014 to 2026

      • 1.3.3 Japan Artemisinin Derivatives Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Artemisinin Derivatives Market Size and Growth Rate of Malaria Treatment from 2014 to 2026

      • 1.4.2 Japan Artemisinin Derivatives Market Size and Growth Rate of Scientific Research from 2014 to 2026

      • 1.4.3 Japan Artemisinin Derivatives Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Artemisinin Derivatives Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Artemisinin Derivatives by Major Types

      • 3.4.1 Market Size and Growth Rate of Dihydroartemisinin

      • 3.4.2 Market Size and Growth Rate of Artemisunate

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Artemisinin Derivatives Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Artemisinin Derivatives by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Artemisinin Derivatives in Malaria Treatment

      • 4.4.2 Market Size and Growth Rate of Artemisinin Derivatives in Scientific Research

      • 4.4.3 Market Size and Growth Rate of Artemisinin Derivatives in Others

    5 Market Analysis by Regions

    • 5.1 Japan Artemisinin Derivatives Production Analysis by Regions

    • 5.2 Japan Artemisinin Derivatives Consumption Analysis by Regions

    6 Hokkaido Artemisinin Derivatives Landscape Analysis

    • 6.1 Hokkaido Artemisinin Derivatives Landscape Analysis by Major Types

    • 6.2 Hokkaido Artemisinin Derivatives Landscape Analysis by Major End-Users

    7 Tohoku Artemisinin Derivatives Landscape Analysis

    • 7.1 Tohoku Artemisinin Derivatives Landscape Analysis by Major Types

    • 7.2 Tohoku Artemisinin Derivatives Landscape Analysis by Major End-Users

    8 Kanto Artemisinin Derivatives Landscape Analysis

    • 8.1 Kanto Artemisinin Derivatives Landscape Analysis by Major Types

    • 8.2 Kanto Artemisinin Derivatives Landscape Analysis by Major End-Users

    9 Chubu Artemisinin Derivatives Landscape Analysis

    • 9.1 Chubu Artemisinin Derivatives Landscape Analysis by Major Types

    • 9.2 Chubu Artemisinin Derivatives Landscape Analysis by Major End-Users

    10 Kinki Artemisinin Derivatives Landscape Analysis

    • 10.1 Kinki Artemisinin Derivatives Landscape Analysis by Major Types

    • 10.2 Kinki Artemisinin Derivatives Landscape Analysis by Major End-Users

    11 Chugoku Artemisinin Derivatives Landscape Analysis

    • 11.1 Chugoku Artemisinin Derivatives Landscape Analysis by Major Types

    • 11.2 Chugoku Artemisinin Derivatives Landscape Analysis by Major End-Users

    12 Shikoku Artemisinin Derivatives Landscape Analysis

    • 12.1 Shikoku Artemisinin Derivatives Landscape Analysis by Major Types

    • 12.2 Shikoku Artemisinin Derivatives Landscape Analysis by Major End-Users

    13 Kyushu Artemisinin Derivatives Landscape Analysis

    • 13.1 Kyushu Artemisinin Derivatives Landscape Analysis by Major Types

    • 13.2 Kyushu Artemisinin Derivatives Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Guangxi Xiancaotang Pharmaceutical

      • 14.1.1 Guangxi Xiancaotang Pharmaceutical Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Sanofi

      • 14.2.1 Sanofi Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Shanghai Natural Bio-engineering Co

      • 14.3.1 Shanghai Natural Bio-engineering Co Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 KPC Pharmaceuticals

      • 14.4.1 KPC Pharmaceuticals Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Guilin Pharmaceutical

      • 14.5.1 Guilin Pharmaceutical Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Kerui Nanhai Pharmaceutical

      • 14.6.1 Kerui Nanhai Pharmaceutical Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Novanat Bioresource

      • 14.7.1 Novanat Bioresource Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Botanical Extracts EPZ Ltd

      • 14.8.1 Botanical Extracts EPZ Ltd Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 104 Figures and 139 Tables)

    • Figure Japan Artemisinin Derivatives Market Size and Growth Rate of Dihydroartemisinin from 2014 to 2026

    • Figure Japan Artemisinin Derivatives Market Size and Growth Rate of Artemisunate from 2014 to 2026

    • Figure Japan Artemisinin Derivatives Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Artemisinin Derivatives Market Size and Growth Rate of Malaria Treatment from 2014 to 2026

    • Figure Japan Artemisinin Derivatives Market Size and Growth Rate of Scientific Research from 2014 to 2026

    • Figure Japan Artemisinin Derivatives Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Artemisinin Derivatives Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Artemisinin Derivatives Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Artemisinin Derivatives

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Artemisinin Derivatives by Different Types from 2014 to 2026

    • Table Consumption Share of Artemisinin Derivatives by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Dihydroartemisinin

    • Figure Market Size and Growth Rate of Artemisunate

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Artemisinin Derivatives by Different End-Users from 2014 to 2026

    • Table Consumption Share of Artemisinin Derivatives by Different End-Users from 2014 to 2026

    • Figure Japan Artemisinin Derivatives Market Size and Growth Rate of Malaria Treatment from 2014 to 2026

    • Figure Japan Artemisinin Derivatives Market Size and Growth Rate of Scientific Research from 2014 to 2026

    • Figure Japan Artemisinin Derivatives Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Artemisinin Derivatives Production by Regions

    • Table Japan Artemisinin Derivatives Production Share by Regions

    • Figure Japan Artemisinin Derivatives Production Share by Regions in 2014

    • Figure Japan Artemisinin Derivatives Production Share by Regions in 2018

    • Figure Japan Artemisinin Derivatives Production Share by Regions in 2026

    • Table Japan Artemisinin Derivatives Consumption by Regions

    • Table Japan Artemisinin Derivatives Consumption Share by Regions

    • Figure Japan Artemisinin Derivatives Consumption Share by Regions in 2014

    • Figure Japan Artemisinin Derivatives Consumption Share by Regions in 2018

    • Figure Japan Artemisinin Derivatives Consumption Share by Regions in 2026

    • Table Hokkaido Artemisinin Derivatives Consumption by Types from 2014 to 2026

    • Table Hokkaido Artemisinin Derivatives Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Artemisinin Derivatives Consumption Share by Types in 2014

    • Figure Hokkaido Artemisinin Derivatives Consumption Share by Types in 2018

    • Figure Hokkaido Artemisinin Derivatives Consumption Share by Types in 2026

    • Table Hokkaido Artemisinin Derivatives Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Artemisinin Derivatives Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Artemisinin Derivatives Consumption Share by End-Users in 2014

    • Figure Hokkaido Artemisinin Derivatives Consumption Share by End-Users in 2018

    • Figure Hokkaido Artemisinin Derivatives Consumption Share by End-Users in 2026

    • Table Tohoku Artemisinin Derivatives Consumption by Types from 2014 to 2026

    • Table Tohoku Artemisinin Derivatives Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Artemisinin Derivatives Consumption Share by Types in 2014

    • Figure Tohoku Artemisinin Derivatives Consumption Share by Types in 2018

    • Figure Tohoku Artemisinin Derivatives Consumption Share by Types in 2026

    • Table Tohoku Artemisinin Derivatives Consumption by End-Users from 2014 to 2026

    • Table Tohoku Artemisinin Derivatives Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Artemisinin Derivatives Consumption Share by End-Users in 2014

    • Figure Tohoku Artemisinin Derivatives Consumption Share by End-Users in 2018

    • Figure Tohoku Artemisinin Derivatives Consumption Share by End-Users in 2026

    • Table Kanto Artemisinin Derivatives Consumption by Types from 2014 to 2026

    • Table Kanto Artemisinin Derivatives Consumption Share by Types from 2014 to 2026

    • Figure Kanto Artemisinin Derivatives Consumption Share by Types in 2014

    • Figure Kanto Artemisinin Derivatives Consumption Share by Types in 2018

    • Figure Kanto Artemisinin Derivatives Consumption Share by Types in 2026

    • Table Kanto Artemisinin Derivatives Consumption by End-Users from 2014 to 2026

    • Table Kanto Artemisinin Derivatives Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Artemisinin Derivatives Consumption Share by End-Users in 2014

    • Figure Kanto Artemisinin Derivatives Consumption Share by End-Users in 2018

    • Figure Kanto Artemisinin Derivatives Consumption Share by End-Users in 2026

    • Table Chubu Artemisinin Derivatives Consumption by Types from 2014 to 2026

    • Table Chubu Artemisinin Derivatives Consumption Share by Types from 2014 to 2026

    • Figure Chubu Artemisinin Derivatives Consumption Share by Types in 2014

    • Figure Chubu Artemisinin Derivatives Consumption Share by Types in 2018

    • Figure Chubu Artemisinin Derivatives Consumption Share by Types in 2026

    • Table Chubu Artemisinin Derivatives Consumption by End-Users from 2014 to 2026

    • Table Chubu Artemisinin Derivatives Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Artemisinin Derivatives Consumption Share by End-Users in 2014

    • Figure Chubu Artemisinin Derivatives Consumption Share by End-Users in 2018

    • Figure Chubu Artemisinin Derivatives Consumption Share by End-Users in 2026

    • Table Kinki Artemisinin Derivatives Consumption by Types from 2014 to 2026

    • Table Kinki Artemisinin Derivatives Consumption Share by Types from 2014 to 2026

    • Figure Kinki Artemisinin Derivatives Consumption Share by Types in 2014

    • Figure Kinki Artemisinin Derivatives Consumption Share by Types in 2018

    • Figure Kinki Artemisinin Derivatives Consumption Share by Types in 2026

    • Table Kinki Artemisinin Derivatives Consumption by End-Users from 2014 to 2026

    • Table Kinki Artemisinin Derivatives Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Artemisinin Derivatives Consumption Share by End-Users in 2014

    • Figure Kinki Artemisinin Derivatives Consumption Share by End-Users in 2018

    • Figure Kinki Artemisinin Derivatives Consumption Share by End-Users in 2026

    • Table Chugoku Artemisinin Derivatives Consumption by Types from 2014 to 2026

    • Table Chugoku Artemisinin Derivatives Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Artemisinin Derivatives Consumption Share by Types in 2014

    • Figure Chugoku Artemisinin Derivatives Consumption Share by Types in 2018

    • Figure Chugoku Artemisinin Derivatives Consumption Share by Types in 2026

    • Table Chugoku Artemisinin Derivatives Consumption by End-Users from 2014 to 2026

    • Table Chugoku Artemisinin Derivatives Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Artemisinin Derivatives Consumption Share by End-Users in 2014

    • Figure Chugoku Artemisinin Derivatives Consumption Share by End-Users in 2018

    • Figure Chugoku Artemisinin Derivatives Consumption Share by End-Users in 2026

    • Table Shikoku Artemisinin Derivatives Consumption by Types from 2014 to 2026

    • Table Shikoku Artemisinin Derivatives Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Artemisinin Derivatives Consumption Share by Types in 2014

    • Figure Shikoku Artemisinin Derivatives Consumption Share by Types in 2018

    • Figure Shikoku Artemisinin Derivatives Consumption Share by Types in 2026

    • Table Shikoku Artemisinin Derivatives Consumption by End-Users from 2014 to 2026

    • Table Shikoku Artemisinin Derivatives Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Artemisinin Derivatives Consumption Share by End-Users in 2014

    • Figure Shikoku Artemisinin Derivatives Consumption Share by End-Users in 2018

    • Figure Shikoku Artemisinin Derivatives Consumption Share by End-Users in 2026

    • Table Kyushu Artemisinin Derivatives Consumption by Types from 2014 to 2026

    • Table Kyushu Artemisinin Derivatives Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Artemisinin Derivatives Consumption Share by Types in 2014

    • Figure Kyushu Artemisinin Derivatives Consumption Share by Types in 2018

    • Figure Kyushu Artemisinin Derivatives Consumption Share by Types in 2026

    • Table Kyushu Artemisinin Derivatives Consumption by End-Users from 2014 to 2026

    • Table Kyushu Artemisinin Derivatives Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Artemisinin Derivatives Consumption Share by End-Users in 2014

    • Figure Kyushu Artemisinin Derivatives Consumption Share by End-Users in 2018

    • Figure Kyushu Artemisinin Derivatives Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Guangxi Xiancaotang Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Guangxi Xiancaotang Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Guangxi Xiancaotang Pharmaceutical

    • Figure Revenue and Market Share Analysis of Guangxi Xiancaotang Pharmaceutical

    • Table Product and Service Introduction of Guangxi Xiancaotang Pharmaceutical

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Shanghai Natural Bio-engineering Co

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Natural Bio-engineering Co

    • Figure Sales and Growth Rate Analysis of Shanghai Natural Bio-engineering Co

    • Figure Revenue and Market Share Analysis of Shanghai Natural Bio-engineering Co

    • Table Product and Service Introduction of Shanghai Natural Bio-engineering Co

    • Table Company Profile and Development Status of KPC Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of KPC Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of KPC Pharmaceuticals

    • Figure Revenue and Market Share Analysis of KPC Pharmaceuticals

    • Table Product and Service Introduction of KPC Pharmaceuticals

    • Table Company Profile and Development Status of Guilin Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Guilin Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Guilin Pharmaceutical

    • Figure Revenue and Market Share Analysis of Guilin Pharmaceutical

    • Table Product and Service Introduction of Guilin Pharmaceutical

    • Table Company Profile and Development Status of Kerui Nanhai Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kerui Nanhai Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Kerui Nanhai Pharmaceutical

    • Figure Revenue and Market Share Analysis of Kerui Nanhai Pharmaceutical

    • Table Product and Service Introduction of Kerui Nanhai Pharmaceutical

    • Table Company Profile and Development Status of Novanat Bioresource

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novanat Bioresource

    • Figure Sales and Growth Rate Analysis of Novanat Bioresource

    • Figure Revenue and Market Share Analysis of Novanat Bioresource

    • Table Product and Service Introduction of Novanat Bioresource

    • Table Company Profile and Development Status of Botanical Extracts EPZ Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Botanical Extracts EPZ Ltd

    • Figure Sales and Growth Rate Analysis of Botanical Extracts EPZ Ltd

    • Figure Revenue and Market Share Analysis of Botanical Extracts EPZ Ltd

    • Table Product and Service Introduction of Botanical Extracts EPZ Ltd

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.